These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28414234)

  • 1. Impact of Mutations at C-Terminus on Structures and Dynamics of Aβ40 and Aβ42: A Molecular Simulation Study.
    Linh NH; Minh Thu TT; Tu L; Hu CK; Li MS
    J Phys Chem B; 2017 May; 121(17):4341-4354. PubMed ID: 28414234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-terminal turn stability determines assembly differences between Aβ40 and Aβ42.
    Roychaudhuri R; Yang M; Deshpande A; Cole GM; Frautschy S; Lomakin A; Benedek GB; Teplow DB
    J Mol Biol; 2013 Jan; 425(2):292-308. PubMed ID: 23154165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the Arctic (E22-->G) mutation on amyloid beta-protein folding: discrete molecular dynamics study.
    Lam AR; Teplow DB; Stanley HE; Urbanc B
    J Am Chem Soc; 2008 Dec; 130(51):17413-22. PubMed ID: 19053400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The structures of the E22Δ mutant-type amyloid-β alloforms and the impact of E22Δ mutation on the structures of the wild-type amyloid-β alloforms.
    Coskuner O; Wise-Scira O; Perry G; Kitahara T
    ACS Chem Neurosci; 2013 Feb; 4(2):310-20. PubMed ID: 23421682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Key Residue for Aggregation of Amyloid-β Peptides.
    Itoh SG; Yagi-Utsumi M; Kato K; Okumura H
    ACS Chem Neurosci; 2022 Nov; 13(22):3139-3151. PubMed ID: 36302506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizing the structural and thermodynamic properties of Aβ42 and Aβ40.
    Lin Y; Im H; Diem LT; Ham S
    Biochem Biophys Res Commun; 2019 Mar; 510(3):442-448. PubMed ID: 30722990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of K16A and K28A mutation on the structure and dynamics of amyloid-β
    Shuaib S; Saini RK; Goyal D; Goyal B
    J Biomol Struct Dyn; 2020 Feb; 38(3):708-721. PubMed ID: 30821624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling.
    Gu L; Tran J; Jiang L; Guo Z
    J Struct Biol; 2016 Apr; 194(1):61-7. PubMed ID: 26827680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico investigation on the inhibition of Aβ
    Dutta M; Mattaparthi VSK
    J Biomol Struct Dyn; 2018 Feb; 36(3):741-752. PubMed ID: 28278027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significantly different contact patterns between Aβ40 and Aβ42 monomers involving the N-terminal region.
    Liu Z; Jiang F; Wu YD
    Chem Biol Drug Des; 2019 Sep; 94(3):1615-1625. PubMed ID: 30381893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid β-Protein Assembly: Differential Effects of the Protective A2T Mutation and Recessive A2V Familial Alzheimer's Disease Mutation.
    Zheng X; Liu D; Roychaudhuri R; Teplow DB; Bowers MT
    ACS Chem Neurosci; 2015 Oct; 6(10):1732-40. PubMed ID: 26244608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of 12-Crown-4 with Alzheimer's Aβ40 and Aβ42 Monomers and Its Effect on Their Conformation: Insight from Molecular Dynamics Simulations.
    Agrawal N; Skelton AA
    Mol Pharm; 2018 Jan; 15(1):289-299. PubMed ID: 29200307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissecting the Molecular Mechanisms of the Co-Aggregation of Aβ40 and Aβ42 Peptides: A REMD Simulation Study.
    Li X; Yang Z; Chen Y; Zhang S; Wei G; Zhang L
    J Phys Chem B; 2023 May; 127(18):4050-4060. PubMed ID: 37126408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solution NMR studies of Aβ monomer dynamics.
    Wang C
    Protein Pept Lett; 2011 Apr; 18(4):354-61. PubMed ID: 21222639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the English familial disease mutation (H6R) on the monomers and dimers of Aβ40 and Aβ42.
    Viet MH; Nguyen PH; Derreumaux P; Li MS
    ACS Chem Neurosci; 2014 Aug; 5(8):646-57. PubMed ID: 24949887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual effects of familial Alzheimer's disease mutations (D7H, D7N, and H6R) on amyloid β peptide: correlation dynamics and zinc binding.
    Xu L; Chen Y; Wang X
    Proteins; 2014 Dec; 82(12):3286-97. PubMed ID: 25137638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G37V mutation of Aβ42 induces a nontoxic ellipse-like aggregate: An in vitro and in silico study.
    Minh Thu TT; Huang SH; Tu LA; Fang ST; Li MS; Chen YC
    Neurochem Int; 2019 Oct; 129():104512. PubMed ID: 31374231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abeta42 is more rigid than Abeta40 at the C terminus: implications for Abeta aggregation and toxicity.
    Yan Y; Wang C
    J Mol Biol; 2006 Dec; 364(5):853-62. PubMed ID: 17046788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
    Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
    Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dimerization Mechanism of Alzheimer Aβ
    Nguyen PH; Sterpone F; Pouplana R; Derreumaux P; Campanera JM
    J Phys Chem B; 2016 Dec; 120(47):12111-12126. PubMed ID: 27933940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.